SynthesisBMC pulmonary medicine2025

Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis.

Linfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.